Introduction: Vitiligo is a relatively common autoimmune depigmenting disorder of the skin.
There has been a great advance in understanding the pathological basis, which has led to …

Vitiligo is an incurable acquired autoimmune disorder resulting in white, hypopigmented
macules and patches caused by the progressive destruction of functional melanocytes (Fig …

Vitiligo is a depigmentation disease that seriously affects the physical health, mental health
and quality of life of a patient. Therapeutic aim at control immunoreaction by relieving …

The present study aimed to investigate the role of janus kinase (JAK) 1/STAT1 in interferon
(IFN)‑γ‑induced apoptosis in human melanocytes. Following IFN‑γ treatment, the viability of …

Background: Vitiligo is a muco-cutaneous, autoimmune, localized, or disseminated disease,
which manifests through hypochromic or achromic macules, with loss in quality of life. The …

There is currently no definitive treatment for vitiligo; various modalities include immune
modulators phototherapy and skin camouflage. We investigated the efficacy and safety of …

Vitiligo is a skin disorder commonly acquired. Although different therapies are used, they are
refractory to therapy in many cases. Trauma has been reported to cause hyperpigmentation …

Background The excimer laser/light (EL) has been reported to be effective for alopecia
areata (AA), but its treatment response has not been systematically reviewed. Objective To …

The psoralens 8-methoxypsoralen (8-MOP), 4, 5′, 8-trimethylpsoralen (TMP) and 5-
methoxypsoralen (5-MOP) find clinical application in PUVA (psoralen+ UVA) therapy. PUVA …

REFERENCES 1. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO
guideline for the definition, classification, diagnosis and management of urticaria. Allergy …